News for Marinus Pharmaceuticals Stock (MRNS)

ROSEN, A LONGSTANDING LAW FIRM, Encourages Marinus Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – MRNS

GlobeNewsWire • 06/11/24

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Marinus Pharmaceuticals, Inc. - MRNS

Accesswire • 06/09/24

The Schall Law Firm Initiates Investigation Into Claims Against Marinus Pharmaceuticals, Inc. And Encourages Investors With Losses To Contact Them

Accesswire • 06/09/24

The Schall Law Firm Has Started Looking Into Allegations Against Marinus Pharmaceuticals, Inc. And Is Urging Investors Who Have Experienced Losses To Reach Out To Them

Accesswire • 06/08/24

The Schall Law Firm Begins Probe Into Accusations Against Marinus Pharmaceuticals, Inc. And Invites Investors Who Have Suffered Losses To Connect

Accesswire • 06/08/24

Marinus Pharmaceuticals Investor Notice: Robbins LLP Reminds Stockholders to Seek Representation in the MRNS Class Action

Business Wire • 06/07/24

The Schall Law Firm Begins Inquiry Into Claims Against Marinus Pharmaceuticals, Inc. And Encourages Investors With Losses To Contact Them

Accesswire • 06/07/24

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Marinus Pharmaceuticals, Inc. with Losses to Contact the Firm

Business Wire • 06/07/24

MARINUS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Marinus Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm

GlobeNewsWire • 06/07/24

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Marinus Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - MRNS

PRNewsWire • 06/07/24

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Marinus Pharmaceuticals, Inc. (MRNS)

GlobeNewsWire • 06/06/24

The Schall Law Firm Initiates Investigation Into Allegations Against Marinus Pharmaceuticals, Inc. And Urges Investors Who Have Incurred Losses To Reach Out

Accesswire • 06/06/24

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Marinus Pharmaceuticals, Inc. - MRNS

GlobeNewsWire • 06/06/24

Class Action Lawsuit Filed on Behalf of Marinus Pharmaceuticals, Inc. (MRNS) Investors – Nationally Ranked Investors' Rights Firm Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm

GlobeNewsWire • 06/06/24

Stockholder Alert: Robbins LLP Informs Investors that a Shareholder Has Filed a Class Action Against Marinus Pharmaceuticals, Inc. (MRNS)

GlobeNewsWire • 06/06/24

MRNS INVESTOR NEWS: ROSEN, A LEADING LAW FIRM, Encourages Marinus Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – MRNS

GlobeNewsWire • 06/06/24

EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit on Behalf of Marinus Pharmaceuticals, Inc. Investors – MRNS

Business Wire • 06/05/24

The Schall Law Firm Begins Probe Into Claims Against Marinus Pharmaceuticals, Inc. And Encourages Investors With Losses To Make Contact

Accesswire • 06/05/24

The Schall Law Firm Initiates Investigation into Allegations Against Marinus Pharmaceuticals, Inc. and Urges Investors with Losses to Reach Out

Accesswire • 06/04/24

MRNS ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Marinus Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm

Accesswire • 06/03/24

IMPORTANT ACTION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Marinus Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm

Accesswire • 06/02/24

IMPORTANT ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Marinus Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm

Accesswire • 06/01/24

IMPORTANT ACTION UPDATE: The Schall Law Firm Announces it is Investigating Claims Against Marinus Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm

Accesswire • 05/31/24

IMPORTANT SHAREHOLDER ALERT: The Schall Law Firm Announces it is Investigating Claims Against Marinus Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm

Accesswire • 05/30/24

IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Marinus Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm

Accesswire • 05/19/24